Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

March 8, 2024

https://www.globenewswire.com/news-release/2024/03/08/2843133/32920/en/Exagen-Inc-to-Participate-in-the-KeyBanc-Capital-Markets-Life-Sciences-MedTech-Investor-Forum.html

CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in one-on-one meetings with investors and a fireside chat on Wednesday, March 20, at 1:30 PM ET.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.